Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

TeraPore Technologies

Request full access

And manufactures high performance filters for protein separations

South San Francisco, United StatesFounded 2013Biotech & Life Sciences

About TeraPore Technologies

TeraPore Technologies provides advanced nanofiltration solutions, focusing on critical separation challenges in biomanufacturing and semiconductor production. The company was founded in 2013 by Dr. Rachel Dorin as a spinout from Cornell University. Dr. Dorin, who serves as the company's CTO, co-invented the core technology during her Ph.D. research in Materials Science and Engineering at Cornell, where she focused on applying self-assembling materials to separation applications. Her academic and research background also includes work at Sandia National Laboratories on nanostructured materials for energy applications.

The company's business revolves around its proprietary "Intelligent Membrane™" technology, which utilizes the self-assembly of block copolymers to create membranes with highly uniform, tunable nanoscale pores. This process allows for the creation of precise filtration systems capable of separating materials at a molecular level, a significant step beyond conventional filters which often have inconsistent pore sizes. TeraPore's revenue is generated through the sale of its filtration products directly to companies in the biopharmaceutical and, in the future, semiconductor industries.

TeraPore's flagship product line is the IsoBlock® VF, a virus filter designed for the downstream purification of biologics like monoclonal antibodies and other cell-derived proteins. A critical step in producing these drugs is the removal of viral contaminants to ensure patient safety. The IsoBlock® VF filter provides robust viral clearance that is less affected by process conditions compared to traditional filters. The product line includes various device sizes and is complemented by the IsoBlock™ PF, an adsorptive pre-filter that removes species that could foul the main virus filter, thereby improving overall throughput. All research, development, and manufacturing, including the polymers for the membranes, are conducted in-house at its South San Francisco facility.

Since its founding, TeraPore has secured significant funding to advance its technology and commercialization efforts. This includes support from government bodies like the National Institutes of Health (NIH) and the National Science Foundation (NSF). The company has completed multiple funding rounds, including a $6M Series A in 2018 and a $10M round in March 2023, bringing its total funding to $19.5M. Key investors include Anzu Partners, RA Capital Management, Artiman Ventures, and Entegris.

Source: Dealroom company data

At a glance

Status
Operational
Employees
13
Open positions
None listed
Dealroom signal
58.8/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, proteomics, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

9 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Mar 2023 $10M $40M Anzu Partners · Entegris · RA Capital Management ↗
SERIES A✓Equity / VC Mar 2018 $6M $24M Anzu Partners · Artiman Ventures · RA Capital Management —
Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Growth signals

TeraPore Technologies website traffic

Latest recorded traffic for TeraPore Technologies is 150 monthly website visits, down 16.7% over the last three months. TeraPore Technologies's team declined 38.1% over the past year.

Latest monthly visits150 3-month web change-16.7% 1-year team growth-38.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

TeraPore Technologies in the South San Francisco ecosystem

Live from Dealroom

The TeraPore Technologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

Series A3 investors entered at this stage

Other known investors3 additional known investors

  • Cornell Tech
  • Cornell University
  • Big Red Ventures
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States92.9%
🇩🇰 Denmark7.1%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about TeraPore Technologies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See TeraPore Technologies’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.